ATX3,ATXN3 Monoclonal antibody proteintech 67057-1-Ig

$449.00
In stock
SKU
67057-1-Ig

 

AT3, ataxin 3, ATX3, ATX3,ATXN3, ATXN3, JOS, MJD, MJD1, SCA3

Host / Isotype: Mouse / IgG2a Class: Monoclonal
Reactivity: Human, Mouse, Pig And More (1) Immunogen: CatNo: Ag6627 Product name: Recombinant human ATX3,ATXN3 protein Source: e coli.-derived, PET28a Tag: 6*His Domain: 1-370 aa of BC033711 Sequence: MESIFHEKQEGSLCAQHCLNNLLQGEYFSPVELSSIAHQLDEEERMRMAEGGVTSEDYRTFLQQPSGNMDDSGFFSIQVISNALKVWGLELILFNSPEYQRLRIDPINERSFICNYKEHWFTVRKLGKQWFNLNSLLTGPELISDTYLALFLAQLQQEGYSIFVVKGDLPDCEADQLLQMIRVQQMHRPKLIGEELAQLKEQRVHKTDLERVLEANDGSGMLDEDEEDLQRALALSRQEIDMEDEEADLRRAIQLSMQGSSRNISQDMTQTSGTNLTSEELRKRREAYFEKQQQKQQQQQQQQQQQQQQQQQQQGDLSGQSSHPCERPATSSGALGSDLGDAMSEEDMLQAAVTMSLETVRNDLKTEGKK Predict reactive species
 Applications: WB, IHC, IF/ICC, ELISA Observed Molecular Weight: 370 aa, 43 kDa
Formulation: PBS, Azide, Glycerol GenBank Accession Number: BC033711
Conjugate: Unconjugated Gene Symbol: ATXN3
Tested Applications: Positive WB detected in Gene ID (NCBI): 4287
Application: Western Blot (WB) RRID: AB_2882368
Dilution: WB : 1:5000-1:50000 Conjugate: Unconjugated
Tested Reactivity: Human, Mouse, Pig Form: Liquid
Host / Isotype: Mouse / IgG2a Background Information: ATXN3, which has deubiquitinase activity and act as a component of the ubiquitin proteasome system, plays a role in transcriptional regulation and neuroprotection. ATXN3 interacts with RAD23, HHR23A and HHR23B, involves in the pathology of MJD. ATXN3 is a mixed-linkage, chain-editing enzyme and that the UIM region of ATXN3 regulates its substrate specificity. Contains an N-terminal deubiquitinating domain, called the Josephin domain, followed by 2 ubiquitin-interacting motifs (UIMs) and a polyQ tract near the C terminus. ATXN3 can be phosphorylated in a protein casein kinase-2-dependent manner, thus the MW would be larger than the predicted one.

 

 

Reviews

Write Your Own Review
You're reviewing:ATX3,ATXN3 Monoclonal antibody proteintech 67057-1-Ig
Your Rating
Copyright © 2025 Biogege, Inc. All rights reserved.